Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03353831
Title Atezolizumab With Bevacizumab and Chemotherapy vs Bevacizumab and Chemotherapy in Early Relapse Ovarian Cancer
Recruitment Recruiting
Gender female
Phase Phase III
Variant Requirements No
Sponsors AGO Research GmbH
Indications

ovarian cancer

peritoneum cancer

fallopian tube cancer

Therapies

Bevacizumab + Paclitaxel

Bevacizumab + Pegylated liposomal-doxorubicin

Atezolizumab + Bevacizumab + Pegylated liposomal-doxorubicin

Atezolizumab + Bevacizumab + Paclitaxel

Age Groups: adult | senior
Covered Countries


No variant requirements are available.